preview medtech riskanalysis
TRANSCRIPT
This presentation was originally conducted by Pete Davis of
Neomend at the MD&M West Conference, Feb 11 2013.
VISIT HERE for the full presentation.
1
To err is human
Pete Davis
VP of Research & Development
Neomend a subsidiary of Bard Davol
2
Really – an R&D guy
presenting risk
analyses??
Risks exist because perfection doesn’t!
3
Communicating to
Management the Value of
Risk Management
4
5
Risk Analysis Steps
• Why Risk Management
• Why ―Communicate‖
• Doing a Hazard Analysis...quickly
• How to ―Communicate‖ to ―Them‖
6
What is important
• It’s about the Specs!
• “A problem well defined is a
problem half solved.”
• John Dewey
7
What does Quality ―control‖?
8
Quality
• Does not Design.
• Does not Manufacture.
• Does not Distribute.
• Use? Possibly.
• Words – No.
• Control? Yes.
9
Again, what does quality
―control‖?
10
Think about these?
11
Any impact on
•Customers
•Patients
•Business
•Environment
12
Thoughts?
13
• ISO 11540:1993 - Caps for writing and marking instruments
intended for use by children up to 14 years of age -- Safety
requirements
• Specifies safety requirements for cap size, ventilated caps
(vent area, air flow) and marking. Annex A describes the
test for air flow. Caps which do not comply should have
the instrument or its packaging labelled with a warning as
to the dangers of asphyxiation from pen caps.
• ASTM D4236 - 94(2005) Standard Practice for Labeling Art
Materials for Chronic Health Hazards
• Scope 1, 1.1... chronic health hazards known to be
associated with a product or product component(s), when
the component(s) is present in a physical form, volume, or
concentration that in the opinion of a toxicologist (see
2.1.11) has the potential to produce a chronic adverse
health effect(s).
Writing Instrument Standards
H
i
g
h
l
i
g
h
t
e
r
14
Importance of Risk Management
• Prepare and respond to your Customers!
• Business strategy
• Business security
• Provide a Competitive advantage
• Communicate information
• Good news
• Bad news
• Not counting everything else
– Regulatory requirement
15
Evolving Process
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Feasiblity
and Research
Prototyping Development Clincal Trial Distribution Post-Market
Survellance
Known Unknown = Risk
Risk needs a multi-functional approach!
16
New requirements
• Medical Device Directive 93/42/EEC (M5)
• Add’s Usability - See Annex I, 1st paragraph
• Subset of Risk Management
• EC 62366 - Medical devices -- Application
of usability engineering to medical devices
17
Structure
Design (ISO
14971)
Process (ISO
14971)
Usability (EC
62366)
New Risks?
Risk Analysis
process
Mitigation & Control
This presentation was originally conducted by Pete Davis of
Neomend at the MD&M West Conference, Feb 11 2013.
VISIT HERE for the full presentation.